Markesbery WR - Search Results

1

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.

Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ. Montine KS, et al. Among authors: markesbery wr. J Neuropathol Exp Neurol. 1998 May;57(5):415-25. doi: 10.1097/00005072-199805000-00005. J Neuropathol Exp Neurol. 1998. PMID: 9596412

2

Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.

Bassett CN, Swift LL, Montine KS, Markesbery WR, Montine TJ. Bassett CN, et al. Among authors: markesbery wr. J Alzheimers Dis. 2002 Feb;4(1):19-30. doi: 10.3233/jad-2002-4103. J Alzheimers Dis. 2002. PMID: 12214015

3

Expression and activities of aldo-keto oxidoreductases in Alzheimer disease.

Picklo MJ, Olson SJ, Markesbery WR, Montine TJ. Picklo MJ, et al. Among authors: markesbery wr. J Neuropathol Exp Neurol. 2001 Jul;60(7):686-95. doi: 10.1093/jnen/60.7.686. J Neuropathol Exp Neurol. 2001. PMID: 11444797

4

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

Montine TJ, Markesbery WR, Morrow JD, Roberts LJ 2nd. Montine TJ, et al. Among authors: markesbery wr. Ann Neurol. 1998 Sep;44(3):410-3. doi: 10.1002/ana.410440322. Ann Neurol. 1998. PMID: 9749613

5

Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins.

Montine KS, Bassett CN, Ou JJ, Markesbery WR, Swift LL, Montine TJ. Montine KS, et al. Among authors: markesbery wr. J Lipid Res. 1998 Dec;39(12):2443-51. J Lipid Res. 1998. PMID: 9831633 Free article.

6

Elevated CSF prostaglandin E2 levels in patients with probable AD.

Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ 2nd, Morrow JD. Montine TJ, et al. Among authors: markesbery wr. Neurology. 1999 Oct 22;53(7):1495-8. doi: 10.1212/wnl.53.7.1495. Neurology. 1999. PMID: 10534257

7

Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

Bassett CN, Neely MD, Sidell KR, Markesbery WR, Swift LL, Montine TJ. Bassett CN, et al. Among authors: markesbery wr. Lipids. 1999 Dec;34(12):1273-80. doi: 10.1007/s11745-999-0478-1. Lipids. 1999. PMID: 10652986

8

Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease.

Reich EE, Markesbery WR, Roberts LJ 2nd, Swift LL, Morrow JD, Montine TJ. Reich EE, et al. Among authors: markesbery wr. Am J Pathol. 2001 Jan;158(1):293-7. doi: 10.1016/S0002-9440(10)63968-5. Am J Pathol. 2001. PMID: 11141503 Free PMC article.

9

4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease.

Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. Montine KS, et al. Among authors: markesbery wr. J Neuropathol Exp Neurol. 1997 Aug;56(8):866-71. doi: 10.1097/00005072-199708000-00004. J Neuropathol Exp Neurol. 1997. PMID: 9258256

10

Lipid peroxidation in aging brain and Alzheimer's disease.

Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, Morrow JD. Montine TJ, et al. Among authors: markesbery wr. Free Radic Biol Med. 2002 Sep 1;33(5):620-6. doi: 10.1016/s0891-5849(02)00807-9. Free Radic Biol Med. 2002. PMID: 12208348 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters